SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 1,387.64 |
Enterprise Value ($M) | 1,477.04 |
Book Value ($M) | 457.60 |
Book Value / Share | 21.81 |
Price / Book | 3.03 |
NCAV ($M) | 72.99 |
NCAV / Share | 3.48 |
Price / NCAV | 19.01 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.03 |
Return on Assets (ROA) | 0.02 |
Return on Equity (ROE) | 0.06 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.81 |
Current Ratio | 3.57 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 519.82 |
Assets | 904.42 |
Liabilities | 446.82 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 486.82 |
Operating Income | 49.53 |
Net Income | 18.78 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 118.96 |
Cash from Investing | -18.51 |
Cash from Financing | 67.44 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Meridian Venture Partners II GP, L.P. | 6.90 | -13.88 | |
13G | Vanguard Group Inc | 6.31 | ||
13G | Rubric Capital Management LP | 5.51 | ||
13G/A | BlackRock Inc. | 12.40 | 27.30 | |
13D/A | Esjay LLC | 4.80 | -4.83 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
11,131 | 63,916 | 17.42 | |
10,151 | 31,284 | 32.45 | |
10,222 | 37,334 | 27.38 | |
27,174 | 80,116 | 33.92 | |
(click for more detail) |
Similar Companies | |
---|---|
ALIM – Alimera Sciences, Inc. | ALPN – Alpine Immune Sciences, Inc. |
ALT – Altimmune, Inc. | APGE – Apogee Therapeutics, Inc. |
APLT – Applied Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io